Arjuna Capital Takeda Pharmaceutical CO LTD Transaction History
Arjuna Capital
- $368 Million
- Q2 2025
A detailed history of Arjuna Capital transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Arjuna Capital holds 55,222 shares of TAK stock, worth $741,079. This represents 0.23% of its overall portfolio holdings.
Number of Shares
55,222Holding current value
$741,079% of portfolio
0.23%Shares
1 transactions
Others Institutions Holding TAK
# of Institutions
381Shares Held
73MCall Options Held
1.68MPut Options Held
157K-
Capital Research Global Investors Los Angeles, CA13.3MShares$178 Million0.04% of portfolio
-
Morgan Stanley New York, NY7.62MShares$102 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY4.5MShares$60.4 Million0.01% of portfolio
-
Ubs Group Ag4.02MShares$54 Million0.01% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA3.71MShares$49.8 Million0.54% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $41.7B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...